About CLINUVEL

RH
Monday, 06 May 2013 13:40

Nomura update "Funds to be used for further clinical development"

CUV has successfully raised AUD6.3mn via a private placement to international institutional and professional investors. The Placement was conducted at price of AUD2.136 per share, representing a 4.3% premium to the 20-day volume weighted average price on April 29 and 15.1% to the closing price on April 30.

Quick Links